General Information
Manufacturer: ViiV Healthcare
Medical Name: Cabotegravir, Rilpivirine
Purpose: Cabenuva is a long-acting injectable medication containing cabotegravir and rilpivirine for treating HIV-1 in eligible adults and adolescents.
Possible Side Effects
| Side Effect | Likelihood |
|---|---|
| Injection site reactions (pain, swelling, etc.) | 79-83% |
| Fever | 8-10% |
| Fatigue | 5-8% |
| Headache | 2-4% |
| Muscle or bone pain | 3-4% |
| Dizziness | 2% |
| Nausea | 1-3% |
| Sleep problems | 1-2% |
| Rash | 1-2% |
| Diarrhea | 1-2% |
Serious but Less Common Side Effects
- Hypersensitivity reactions
- Post-injection reactions
- Liver problem
- Depression or mood changes
Preconditions and Warnings
- 12 years and older
- Weigh at least 77 lbs (35 kg)
- Have ever had an allergic reaction to cabotegravir or rilpivirine.
- Are taking certain medicines: carbamazepine; oxcarbazepine; phenobarbital; phenytoin; rifabutin; rifampin; rifapentine; dexamethasone (more than a single-dose treatment); St John’s wort (Hypericum perforatum).